Dose and normal tissue complication probability analysis of various radiotherapy regimens for thymomas
All four plans meet the thymoma target dose requirement. However, NONCO-VMAT is preferred for its advantages in multi-organ protection and balanced breast dose. Additionally, CO-VMAT should be used cautiously in female patients due to the higher breast dose.
Authors
- Zhichao Wang (ORCID: https://orcid.org/0000-0002-0136-1911)
- Wu Xiandong
- Hu Yan
- Li Chao
- Luo Haifeng
- Li Jingjing
Institutions
- First People's Hospital of Jingzhou (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2026-02-05
- DOI
- https://doi.org/10.3389/fonc.2026.1730138
- Primary Topic
- Myasthenia Gravis and Thymoma
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Natural Science Foundation of Hubei Province